PA
Profund Advisors Portfolio holdings
AUM
$2.78B
This Quarter Return
+3.74%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.13B
AUM Growth
+$2.13B
(-6.4%)
Cap. Flow
-$163M
Cap. Flow
% of AUM
-7.65%
Top 10 Holdings %
Top 10 Hldgs %
25.78%
Holding
1,594
New
34
Increased
424
Reduced
852
Closed
284
Top Buys
| 1 |
Gilead Sciences
GILD
|
$6.62M |
| 2 |
Apple
AAPL
|
$5.98M |
| 3 |
Amgen
AMGN
|
$5.55M |
| 4 |
Microsoft
MSFT
|
$4.92M |
| 5 |
AbbVie
ABBV
|
$4.44M |
Top Sells
| 1 |
Exxon Mobil
XOM
|
$5.14M |
| 2 |
Schlumberger
SLB
|
$3.43M |
| 3 |
Freeport-McMoran
FCX
|
$2.81M |
| 4 |
Chevron
CVX
|
$2.78M |
| 5 |
Duke Energy
DUK
|
$2.5M |
Sector Composition
| 1 | Healthcare | 31.2% |
| 2 | Technology | 14.82% |
| 3 | Energy | 7.97% |
| 4 | Financials | 7.89% |
| 5 | Communication Services | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$140B
| $113M | 5.31% | 1,064,073 +62,234 | +6% | +$6.62M |
|
|
2
Amgen
AMGN
$155B
| $75.1M | 3.52% | 534,346 +39,540 | +8% | +$5.55M |
|
|
3
AbbVie
ABBV
$372B
| $59.8M | 2.8% | 1,034,794 +76,797 | +8% | +$4.44M |
|
4
Biogen
BIIB
$19.4B
| $55M | 2.58% | 166,253 +12,020 | +8% | +$3.98M |
|
|
5
Apple
AAPL
$3.45T
| $53.5M | 2.51% | 531,116 +59,381 | +13% | +$5.98M |
|
|
CELG
6
DELISTED
Celgene Corp
CELG
| $53.4M | 2.5% | 563,029 +40,099 | +8% | +$3.8M |
|
7
Intel
INTC
$107B
| $38.3M | 1.79% | 1,099,638 +23,673 | +2% | +$824K |
|
8
Alphabet (Google) Class C
GOOG
$2.58T
| $37.4M | 1.75% | 64,262 +6,110 | +11% | +$3.56M |
|
|
9
Microsoft
MSFT
$3.77T
| $34.2M | 1.6% | 736,647 +106,097 | +17% | +$4.92M |
|
10
Johnson & Johnson
JNJ
$427B
| $30.6M | 1.43% | 287,077 +39,203 | +16% | +$4.18M |
|
|
11
Exxon Mobil
XOM
$487B
| $26.8M | 1.26% | 285,393 -54,634 | -16% | -$5.14M |
|
|
ALXN
12
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $23.1M | 1.08% | 139,432 +9,630 | +7% | +$1.6M |
|
13
Meta Platforms (Facebook)
META
$1.86T
| $20.1M | 0.94% | 254,122 +23,815 | +10% | +$1.88M |
|
14
Regeneron Pharmaceuticals
REGN
$61.5B
| $19.2M | 0.9% | 53,317 -289 | -0.5% | -$104K |
|
15
Pfizer
PFE
$141B
| $18.9M | 0.88% | 638,931 +86,136 | +16% | +$2.55M |
|
16
Vertex Pharmaceuticals
VRTX
$100B
| $18.9M | 0.88% | 168,126 +13,893 | +9% | +$1.56M |
|
17
Amazon
AMZN
$2.44T
| $18.4M | 0.86% | 56,940 +4,452 | +8% | +$1.44M |
|
18
Merck
MRK
$210B
| $17.4M | 0.82% | 293,866 +37,921 | +15% | +$2.25M |
|
19
Illumina
ILMN
$15.8B
| $15.7M | 0.73% | 95,599 +13,253 | +16% | +$2.17M |
|
|
20
Chevron
CVX
$324B
| $15.5M | 0.73% | 130,110 -23,305 | -15% | -$2.78M |
|
|
21
Schlumberger
SLB
$55B
| $13M | 0.61% | 127,630 -33,738 | -21% | -$3.43M |
|
22
Wells Fargo
WFC
$263B
| $12.1M | 0.57% | 232,890 +23,199 | +11% | +$1.2M |
|
23
Comcast
CMCSA
$125B
| $11.8M | 0.55% | 219,593 +24,131 | +12% | +$1.3M |
|
24
Cisco
CSCO
$274B
| $11.5M | 0.54% | 456,732 +41,786 | +10% | +$1.05M |
|
25
JPMorgan Chase
JPM
$829B
| $11.4M | 0.54% | 189,912 +19,220 | +11% | +$1.16M |
|